Editorial for the Special Issue—“Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies”-Reference-Cited by-同舟云学术

Editorial for the Special Issue—“Recent Advances of Novel Pharmaceutical Designs for Anti-Cancer Therapies”

Published:2023-05-05 Issue:9 Volume:24 Page:8238
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Biersack Bernhard¹^ORCID

Affiliation:

1. Organische Chemie 1, Universität Bayreuth, Universitätsstrasse 30, 95440 Bayreuth, Germany

Abstract

Cancer is one of the leading causes of death worldwide, despite the promising developments in terms of the curing and management of certain cancer types that have occurred over the last decades saving and prolonging the lives of numerous patients [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/9/8238/pdf

Reference9 articles.

1. Zhou, X., Fu, Y.-H., Zou, Y.-Y., Meng, J., Ou-Yang, G.-P., Ge, Q.-S., and Wang, Z.-C. (2022). Discovery of simple diacylhydrazine functionalized cinnamic acid derivatives as potential microtubule stabilizers. Int. J. Mol. Sci., 23.

2. Wawszczyk, J., Jesse, K., and Kapral, M. (2023). Pterostilbene-mediated inhibition of cell proliferation and cell death induction in amelanotic and melanotic melanoma. Int. J. Mol. Sci., 24.

3. Bhattacharyya, S., Ghosh, H., Covarrubias-Zambrano, O., Jain, K., Swamy, K.V., Kasi, A., Hamza, A., Anant, S., VanSaun, M., and Weir, S.J. (2023). Anticancer activity of novel difluorinated curcumin analog and its inclusion complex with 2-hydroxypropyl-β-cyclodextrin against pancreatic cancer. Int. J. Mol. Sci., 24.

4. Broni, E., Striegel, A., Ashley, C., Sakyi, P.O., Peracha, S., Velazquez, M., Bebla, K., Sodhi, M., Kwofie, S.K., and Ademokunwa, A. (2023). Molecular docking and dynamics simulation studies predict potential anti-ADAR2 inhibitors: Implications for the treatment of cancer, neurological, immunological and infectious diseases. Int. J. Mol. Sci., 24.

5. Schleser, S.W., Ghosh, H., Hörner, G., Seib, J., Bhattacharyya, S., Weber, B., Schobert, R., Dandawate, P., and Biersack, B. (2023). New 4,5-diarylimidazol-2-ylidene-iodidogold(I) complexes with high activity against esophageal adenocarcinoma cells. Int. J. Mol. Sci., 24.